LENVIMA 10 Mg (LENVATINIB 10 mg)
| Active Ingredient | Lenvatinib |
|---|---|
| Manufacturers | Eisai Pharmaceuticals India Pvt. Ltd |
| Indications | Thyroid cancer |
| Strength | 10mg |
| Packaging | 10 Tablets in 1 Strip |
| Delivery Time | 6 To 15 days |
LENVIMA 10 mg contains Lenvatinib, a targeted therapy medication used to treat certain types of cancer, including thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer). Lenvatinib belongs to a class of drugs known as tyrosine kinase inhibitors, which block specific enzymes that promote cancer cell growth.
It is usually prescribed for patients who cannot undergo surgery or whose cancer has spread to other parts of the body. LENVIMA 10 mg is taken orally, once a day, with or without food, and requires regular medical supervision due to possible side effects and interactions.
Important: Only use Lenvatinib under the guidance of a qualified oncologist. Routine blood tests and monitoring are essential during treatment.








There are no reviews yet.